Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.

According to numerous recent publications, the COVID-19 patients have lymphopenia, higher infection-related biomarkers and several elevated inflammatory cytokines (i.e. tumor necrosis factor (TNF)-α, interleukin IL-2R and IL-6).

COVID-19 and the nicotinic cholinergic system.

https://bit.ly/2zfUZ1S